MoH probes rising misuse of Diabetes drug Ozempic for weight loss
Health Principal Secretary Mary Muthoni confirmed the probe on Thursday and said the Pharmacy and Poisons Board (PPB) is handling the matter following concerns from medical experts.
The Health Ministry has launched investigations into the misuse of Ozempic, a diabetes drug that many Kenyans are now using for weight loss, raising fears of health risks and shortages for patients who need it to manage Type 2 diabetes.
Health Principal Secretary Mary Muthoni confirmed the probe on Thursday and said the Pharmacy and Poisons Board (PPB) is handling the matter following concerns from medical experts.
"Ozempic was developed to help people living with Type 2 diabetes, but we have noted with concern that many people are now using it for weight loss without medical guidance," Muthoni said.
"Our Pharmacy and Poisons Board (PPB) is currently looking into all concerns over the misuse of Ozempic, and I am sure we will have a good report around that. Drugs must always be prescribed by a qualified medical professional. Ensure that you do not walk into a pharmacy or a supermarket by yourself," she added.
The ministry is worried about a growing trend where Kenyans self-prescribe the drug despite its intended use being strictly under medical supervision.
Ozempic was approved by US authorities for weight loss and has received praise for its benefits, including rapid weight loss and added protection for the heart and kidneys.
In Kenya, the drug has become popular after being promoted by celebrities who have credited it with helping them lose weight without exercise or dieting.
But health experts have warned against such use, saying these drugs carry serious risks for people who are not diabetic.
Obese youth may be prescribed similar drugs such as liraglutide, semaglutide (Ozempic/Wegovy), or tirzepatide (Mounjaro/Zepbound), but only under strict medical supervision.
These medications help the pancreas produce insulin, but misuse can lead to low blood sugar or even life-threatening conditions like ketosis.
Doctors have also raised concern over emerging research linking the drugs to possible mental health issues, a subject that remains largely unexamined despite the growing trend of using Ozempic for weight loss.
